C12Y 304/22008
Clostripain
Official title: Clostripain (3.4.22.8)
C12Y304/22008 (Clostripain) appears on 4 US grants and 8 published applications in this corpus.
Search patents in C12Y- Granted patents
- 4
- Published applications
- 8
- Assignees
- 7
- Inventors
- 21
- Latest grant
- 23 Aug 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 1 |
| 2022 | 2 | 1 |
| 2023 | 0 | 2 |
By publication year.
Recent patents
- Methods of treating neurological disorders23 Aug 2022US 11,419,921 B2EnClear Therapies, Inc.
- Bacterial strain clostridium histolyticum and methods of use thereof11 Jan 2022US 11,220,666 B2MB Pharma s.r.o.
- BMP peptides and methods of use23 Oct 2018US 10,106,591 B2LifeNet Health
- Method for purifying enzymes from clostridium histolyticum using multi-stage chromatography1 Aug 2006US 7,083,964 B2Nordmark Arzneimittel GmbH & Co. KG
- Methods of treating neurological disorders23 Feb 2023US 2023/0056486 A1EnClear Therapies, Inc.
- Preparation of adipose tissue-derived cell population5 Jan 2023US 2023/0002750 A1Amano Enzyme Inc.
- Chromatographic purification of at least one enzyme selected from a group including collagenase type i, collagenase type ii, neutral protease and clostripain5 May 2022US 2022/0135617 A1Nordmark Pharma GmbH
- Methods of treating neurological disorders27 May 2021US 2021/0154276 A1EnClear Therapies, Inc.
- Bacterial strain clostridium histolyticum and its use29 Oct 2020US 2020/0339941 A1MB Pharma s.r.o.
Most cited
By later US patents